Loading company…
Worg Pharmaceuticals develops treatments and diagnostic tools for allergy and autoimmune diseases.
Founded in 2018 and based in Shanghai, Worg Pharmaceuticals develops products for allergy and autoimmune diseases using its PCFiT and Apitope platforms. Its pipeline includes WP1048, WP1049 and WP1073, as well as a molecular allergy diagnostic platform. In December 2025, it raised over CNY 300 million in Series D+ funding to advance global clinical trials and internationalize its products and pipeline.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in